These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31426870)

  • 1. Tigecycline-induced sustained severe hypoglycemia: a case report.
    Chen Y; Li L; Zhang N; Li H
    BMC Pharmacol Toxicol; 2019 Aug; 20(1):50. PubMed ID: 31426870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tigecycline-Induced Severe Hypoglycemia in a Non-Diabetic Individual: A Case Report and Brief Review of Tigecycline-Induced Severe Hypoglycemia.
    Ray A; Sharma S; Atal S; Sadasivam B; Jhaj R
    Am J Case Rep; 2020 Jul; 21():e924556. PubMed ID: 32667905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Monte Carlo simulation to evaluate the efficacy of tigecycline and minocycline for the treatment of pneumonia due to carbapenemase-producing Klebsiella pneumoniae.
    Ni W; Li G; Zhao J; Cui J; Wang R; Gao Z; Liu Y
    Infect Dis (Lond); 2018 Jul; 50(7):507-513. PubMed ID: 29316830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tigecycline for treatment of carbapenem-resistant Klebsiella pneumoniae infections after liver transplantation in the intensive care unit: a 3-year study.
    Mouloudi E; Massa E; Piperidou M; Papadopoulos S; Iosifidis E; Roilides I; Theodoridou T; Kydona C; Fouzas I; Imvrios G; Papanikolaou V; Gritsi-Gerogianni N
    Transplant Proc; 2014 Nov; 46(9):3219-21. PubMed ID: 25420864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraventricular tigecycline for the treatment of shunt infection: a case in pediatrics.
    Curebal B; Dalgic N; Bayraktar B
    J Neurosurg Pediatr; 2018 Nov; 23(2):247-250. PubMed ID: 30497136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tigecycline for treatment of pneumonia and empyema caused by carbapenemase-producing Klebsiella pneumoniae.
    Daly MW; Riddle DJ; Ledeboer NA; Dunne WM; Ritchie DJ
    Pharmacotherapy; 2007 Jul; 27(7):1052-7. PubMed ID: 17594211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of bacterial load on pharmacodynamics and susceptibility breakpoints for tigecycline and Klebsiella pneumoniae.
    Tsala M; Vourli S; Daikos GL; Tsakris A; Zerva L; Mouton JW; Meletiadis J
    J Antimicrob Chemother; 2017 Jan; 72(1):172-180. PubMed ID: 27650184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and safety of high-dose tigecycline-containing regimens for the treatment of severe bacterial infections.
    Falagas ME; Vardakas KZ; Tsiveriotis KP; Triarides NA; Tansarli GS
    Int J Antimicrob Agents; 2014 Jul; 44(1):1-7. PubMed ID: 24602499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case report of drug-induced liver injury after tigecycline administration: histopathological evidence and a probable causality grading as assessed by the updated RUCAM diagnostic scale.
    Shi X; Lao D; Xu Q; Li X; Lv Q
    BMC Infect Dis; 2022 Apr; 22(1):368. PubMed ID: 35410140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tigecycline therapy for infections due to carbapenemase-producing Klebsiella pneumoniae in critically ill patients.
    Balandin Moreno B; Fernández Simón I; Pintado García V; Sánchez Romero I; Isidoro Fernández B; Romera Ortega MA; Alcántara Carmona S; Pérez Redondo M; Galdos Anuncibay P
    Scand J Infect Dis; 2014 Mar; 46(3):175-80. PubMed ID: 24354959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The efficacy and safety of different antimicrobial regimens in carbapenem-resistant
    Sun WM; Zhou H; Shen LS; Yang Q; Ma WJ; Zhou JY
    Zhonghua Nei Ke Za Zhi; 2019 Aug; 58(8):566-571. PubMed ID: 31365977
    [No Abstract]   [Full Text] [Related]  

  • 12. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
    Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and risk factors of tigecycline-associated hypofibrinogenaemia in critically ill patients.
    Hu J; Xiao YH; Zheng Y; Lai YX; Fang XL; Fang Q
    Eur J Clin Pharmacol; 2020 Jul; 76(7):913-922. PubMed ID: 32355990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests.
    Jean SS; Hsieh TC; Hsu CW; Lee WS; Bai KJ; Lam C
    J Microbiol Immunol Infect; 2016 Dec; 49(6):924-933. PubMed ID: 26341302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tigecycline-based versus sulbactam-based treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
    Ye JJ; Lin HS; Yeh CF; Wu YM; Huang PY; Yang CC; Huang CT; Lee MH
    BMC Infect Dis; 2016 Aug; 16():374. PubMed ID: 27496018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tigecycline resistance caused by rpsJ evolution in a 59-year-old male patient infected with KPC-producing Klebsiella pneumoniae during tigecycline treatment.
    He F; Shi Q; Fu Y; Xu J; Yu Y; Du X
    Infect Genet Evol; 2018 Dec; 66():188-191. PubMed ID: 30268919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delirium induced by tigecycline treatment for Acinetobacter baumannii infection: A case report.
    Zheng X; Jiang H; Xue L; Qiu F; Zhu S; Li X
    Medicine (Baltimore); 2019 May; 98(19):e15399. PubMed ID: 31083168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence and characterization of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae isolates from blood samples of patients in intensive care units in northern China.
    Xu H; Zhou Y; Zhai X; Du Z; Wu H; Han Y; Huo C; Chen Y
    J Med Microbiol; 2016 Aug; 65(8):751-759. PubMed ID: 27324378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tigecycline Therapy for Nosocomial Pneumonia due to Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Who Received Inappropriate Initial Antibiotic Treatment: A Retrospective Case Study.
    Wu X; Zhu Y; Chen Q; Gong L; Lin J; Lv D; Feng J
    Biomed Res Int; 2016; 2016():8395268. PubMed ID: 28044137
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute liver failure caused by high-dose tigecycline: A case report.
    Zhang Y; Wang J; Tan Y; Wu J
    Int J Clin Pharmacol Ther; 2024 Jul; 62(7):339-344. PubMed ID: 38606856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.